Category: Drug Discovery
Global Drug Discovery
-
Vaginitis Therapeutics Market Forecasts to 2030 – Global Analysis By Disease Type (Atrophic Vaginitis, Bacterial vaginosis (BV), Trichomoniasis and Other Disease Types), By Treatment (Prescription Drugs, Natural and Herbal Remedies, Over-the-counter (OTC) Drugs and Probiotics and Vaginal Suppositories), Distribution Channel and By Geography
... and Vaginal Suppositories), Distribution Channel and By Geography According to Stratistics MRC, the Global Vaginitis Therapeutics Market is accounted for $3.52 billion in 2023 and is expected to reach $7.01 billion by 2030 growing at ... Read More
-
2024 Global Forecast for Epilepsy Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Epilepsy Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Liver Disease Therapeutics - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
... expected to grow at a steady CAGR forecast till 2028 owing to increased alcohol consumption associated with causing liver damage and increasing research and development activities The global liver disease therapeutics market was valued at ... Read More
-
Small Molecule API Global Market Report 2024
... Albemarle Corporation; Boehringer Ingelheim International GmbH Small Molecule API Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This ... Read More
-
Albumin Market Report by Product (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), Application (Therapeutics, Drug Formulation and Vaccine, Component of Media, and Others), End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Research Institutes), and Region 2024-2032
... and Region 2024-2032 The global albumin market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% ... Read More
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2024-2032
... and Region 2024-2032 The global cephalosporin market size reached US$ 19.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 2.6% ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
-
Hepatitis B Virus (HBV) Global Market Report 2024
... Healthcare PayersCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmon La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc. Hepatitis B Virus (HBV) Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Generative AI in Pharmaceutical Market Report: Trends, Forecast and Competitive Analysis to 2030
... the clinical trial research, drug discovery, research and development markets. Generative AI in the global pharmaceutical market is expected to grow with a CAGR of 29.5% from 2024 to 2030. The major drivers for this ... Read More
-
Biosimulation Market Report: Trends, Forecast and Competitive Analysis to 2030
... academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding ... Read More
-
Biomarkers Market Size, Share & Trends Analysis Report By Type (Efficacy, Validation), By Product, By Application (Drug Discovery & Development, Personalized Medicine), By Disease, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global biomarkers market size is expected to reach USD 194.21 billion by 2030, registering a CAGR of 13.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Cutaneous and Systemic Leishmaniasis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and
... Africa) The global Cutaneous and Systemic Leishmaniasis market is on an upward trajectory over the forecast period 2024-2031. This growth can be attributed to several key factors that are driving the market's expansion. High Clinical ... Read More
-
Biosimulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... technique harnessing computer programs to simulate biological processes, is revolutionizing the field of drug discovery and development. This innovative tool allows researchers to predict the outcomes of experiments related to drug development, significantly reducing the ... Read More
-
Vaginitis Therapeutics Global Market Report 2024
... Hospitals; Ambulatory Surgical Centers; Specialized Gynecology Centers; ClinicsCovering: Pfizer Inc.; Merck & Co Inc.; Novartis AG; Bayer AG; Lupin Pharmaceuticals Inc. Vaginitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Global Amino Acid Analyzer for Industrial, Preclinical, and Clinical Usage Market 2024-2028
... CAGR of 5.76% during the forecast period. The report on the amino acid analyzer for the industrial, preclinical, and clinical usage market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, ... Read More
-
Single-Cell Multi-Omics Market by Type (Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics), Technique (Single-Cell Analysis, Single-Cell Isolation & Dispensing), Application, End User - Global Forecast 2024-2030
... at USD 2.92 billion in 2023 and expected to reach USD 3.18 billion in 2024, at a CAGR 10.65% to reach USD 5.93 billion by 2030. Global Single-Cell Multi-Omics Market FPNV Positioning Matrix The FPNV ... Read More
-
Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Global Forecast 2024-2030
... reach USD 8.08 billion in 2024, at a CAGR 4.94% to reach USD 11.06 billion by 2030. Global Schizophrenia Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Schizophrenia Therapeutics ... Read More
-
Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Disease Stage (Early, Moderate, Severe), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 7.26 billion in 2024, at a CAGR 8.00% to reach USD 11.57 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's Disease ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Global Forecast 2024-2030
... reach USD 22.14 billion in 2024, at a CAGR 5.82% to reach USD 31.12 billion by 2030. Global Lifestyle Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lifestyle Drugs ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Animal Biotechnology Market by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs), Application (Development of Animal Pharmaceuticals, Food Safety & Drug Development, Preventive Care for Animals) - Global Forecast 2024-2030
... was estimated at USD 28.64 billion in 2023 and expected to reach USD 31.04 billion in 2024, at a CAGR 8.46% to reach USD 50.59 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Eczema Therapeutics Market by Treatment (Antibiotics, Antihistamines, Calcineurin Inhibitors), Distribution Channel (Hospital & Clinics, Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... and expected to reach USD 7.49 billion in 2024, at a CAGR 9.59% to reach USD 13.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Eczema Therapeutics Market. ... Read More
-
Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Global Forecast 2024-2030
... 3.15 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 10.88% to reach USD 6.51 billion by 2030. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market FPNV Positioning Matrix The FPNV ... Read More
Research Assistance
